Related Experiment Video
Updated: Jan 18, 2026

Stable Knockdown of Genes Encoding Extracellular Matrix Proteins in the C2C12 Myoblast Cell Line Using Small-Hairpin shRNA
Published on: February 12, 2020
Early regulation and alternative splicing dynamics in glucocorticoid muscle atrophy revealed by temporal omics in
Suzuka Nakagawa1,2, Aristotelis Misios1, Oliver Popp1
1Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Abstract:
Skeletal muscle atrophy and weakness are major contributors to morbidity, prolonged recovery, and long-term disability across a wide range of diseases. Atrophy is caused by the breakdown of sarcomeric proteins, resulting in loss of muscle mass and strength. Molecular mechanisms underlying the onset of muscle atrophy and its progression have been analyzed in patients, mice, and cell culture, but the complementarity of these model systems remains to be explored. Here, we applied deep coverage transcriptomic and proteomic profiling for an updated view on dynamic changes during dexamethasone-induced atrophy in the widely used murine skeletal muscle cell line C2C12. Comparison with published mouse data confirmed that muscle differentiation is well recapitulated in C2C12 myotubes. Under dexamethasone treatment, this model was particularly suited to capture early atrophy events. We additionally identified alterations in mitochondrial gene expression and differential alternative splicing events during early-stage myotube atrophy. This dataset complements existing in vivo data and provides novel insights into the regulatory processes during skeletal muscle wasting.NEW & NOTEWORTHY Skeletal muscle atrophy studies rely on in vivo mouse data as well as in vitro data. Our deep coverage transcriptome and proteome data reveal that the commonly used C2C12 cells faithfully recapitulate differentiation and atrophy markers, with significant alternative splicing occurring under dexamethasone atrophy. Using published mouse tissue data of comparable methods, we provide an up-to-date resource for skeletal muscle atrophy to complement animal studies.
Insights
Skeletal muscle atrophy research benefits from C2C12 cells, which accurately model muscle wasting and differentiation. This study provides deep molecular insights into early atrophy events and alternative splicing, complementing existing animal data.
Area of Science:
- Biochemistry and Molecular Biology
- Cell Biology
- Physiology
Background:
- Skeletal muscle atrophy and weakness contribute significantly to disease morbidity, recovery time, and long-term disability.
- Understanding the molecular mechanisms of muscle atrophy is crucial for developing effective interventions.
- Complementarity of in vivo and in vitro models for studying muscle atrophy requires further exploration.
Purpose of the Study:
- To provide an updated view of dynamic changes during dexamethasone-induced atrophy using deep transcriptomic and proteomic profiling in the C2C12 murine skeletal muscle cell line.
- To assess the suitability of C2C12 cells as a model for studying early atrophy events and compare it with existing in vivo mouse data.
- To identify molecular alterations, including gene expression and alternative splicing, during early-stage myotube atrophy.
Main Methods:
- Deep coverage transcriptomic and proteomic profiling of C2C12 myotubes.
- Induction of skeletal muscle atrophy using dexamethasone.
- Comparison of C2C12 cell data with published in vivo mouse skeletal muscle data.
- Analysis of gene expression, particularly mitochondrial genes, and alternative splicing events.
Main Results:
- C2C12 myotubes effectively recapitulate muscle differentiation and atrophy markers, validating their use as an in vitro model.
- Dexamethasone treatment in C2C12 cells captured early molecular events characteristic of skeletal muscle atrophy.
- Identified significant alterations in mitochondrial gene expression and differential alternative splicing during early atrophy.
- The generated dataset complements existing in vivo data, offering a valuable resource for skeletal muscle atrophy research.
Conclusions:
- The C2C12 cell line is a suitable and valuable model for studying the molecular mechanisms of skeletal muscle atrophy, particularly early events.
- Deep molecular profiling reveals significant alternative splicing and mitochondrial gene expression changes during dexamethasone-induced atrophy.
- This study provides a comprehensive dataset that complements in vivo findings and enhances our understanding of skeletal muscle wasting.
- The findings offer novel insights into the regulatory processes underlying muscle atrophy, aiding future therapeutic strategies.
Related Concept Videos
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Master Transcription Regulators
What is Gene Expression?

